Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2003-04-23
2009-06-30
Parkin, Jeffrey S. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S324000, C530S325000, C530S326000, C530S327000
Reexamination Certificate
active
07553926
ABSTRACT:
Peptides representing sequences from region 45-74 of the human CD38 leukocyte surface antigen (SEQ ID NO:1) are provided which may be used to inhibit or prevent transmission or replication of the HIV virus. The peptides have from 13 to 30 amino acids and include the amino acid sequence GPGTTK (SEQ ID NO:18) for topical application to inhibit or prevent transmission of the HIV virus.
REFERENCES:
patent: 5622933 (1997-04-01), Sabatier et al.
patent: 5800822 (1998-09-01), Sia et al.
patent: 6114143 (2000-09-01), Eda et al.
patent: 6193981 (2001-02-01), Goldstein
patent: 6258932 (2001-07-01), Vahlne
patent: WO 93/04693 (1993-03-01), None
patent: WO 94/17184 (1994-08-01), None
Savarino, A., et al., 1999, Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle, The FASEB J. 13:2265-2276.
Munshi, C., et al., 1999, “Characterization of the active site of ADP-ribosyl cyclase”, J. Biol. Chem. 274(43):30770-7 (abstract provided).
Munshi, C., et al., 2000, “Identification of the enzymatic active site of CD38 by site-directed mutagenesis”, J. Biol. Chem. 275(28): 21566-71 (abstract provided).
Tohgo, A., et al., 1997, “Lysine 129 of CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) participates in the binding of ATP to inhibit the cyclic ADP-ribose hydrolase”, J. Biol. Chem. 272(7):3879-82 (abstract provided).
Hoshino, S., et al., 1997, “Mapping of the catalytic and epitopic sites of human CD38/NAD+ glycohydrolase to a functional domain in the carboxyl terminus”, J. Immunol. 158(2):741-7 (abstract provided).
Savarino, et al., Human CD38 interferes with HIV-1 fusion through a sequence homologous to the V3 loop of the viral envelope glycoprotein gp1201. The FASEB Journal, 2003, vol. 17, p. 461-463.
Fantini, et al., Multi-branched peptides based on the HIV-1 V3 loop consensus motif inhibit HIV-1 and HIV-2 infection in CD4+and CD4−cells. C. R. Acad. Sci. Paris, Sciences de la vie/Life sciences, 1993, vol. 316, p. 1381-7.
Yahi, et al., Multibranched V3 Peptides Inhibit Human Immunodeficiency Virus Infection in Human Lymphocytes and Macrophages. Journal of Virology, 1994, p. 5714-5720.
Fantini Jacques et al., Multi-Branched Peptides Based on the HIV-1 V3 Loop Consensus Motif Inhibit HIV-1 and HIV-2 Infection in CD4+ and CD4− Cells, Comptes Rendus De L'Academie Des Sciences, Serie III Sciences de la Vie, vol. 316, No. 11, 1993, pp. 1381-1387.
Savarino Andrea et al., Human CD38 Interferes with HIV-1 Fusion Through a Sequence Homologous to the V3 Loop of the Viral Envelope Glycoprotein gp120, FASEB Journal, vol. 17, No. 3, Mar. 2003, pp. 461-463.
Savarino Andrea et al., Human CD38 Interferes with HIV-1 Fusion Through a Sequence Homologous to the V3 Loop of the Viral Envelope Glycoprotein gp120, FASEB Journal Online, Jan. 22, 2003, pp. 1-20.
Yahi Nouara et al., Multibranched V3 Peptides Inhibit Human Immunodeficiency Virus Infection in Human Lymphocytes and Macrophages, Journal of Virology, The American Society for Microbiology, vol. 68, No. 9, Sep. 1994, pp. 5714-5720.
Jackson D.G., et al., Isolation of a Complementary DNA Encoding the Human CD38 T10 Molecule, a Cell Surface Glycoprotein with an Unusual Discontinuous Pattern of Expression During Lymphocyte Differentiation, Database NCBI Sep. 29, 1999, from NCBI Database Accession No. A43521.
Similarities in Amino Acid Sequences of Aplysia ADP-Ribosyl Cyclase and Human Lymphocyte Antigen CD38. TIBS, 1992, pp. 494-495.
Tohgo, et al., Essential Cysteine Residues for Cyclic ADP-ribose Synthesis and Hydrolysis by CD38. The Journal of Biological Chemistry, 1994, vol. 46, pp. 28555-28557.
Nata, Et al., Human Gene Encoding CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase): Organization, Nucleotide Sequence and Alternative Splicing. GENE—An International Journal on Genes and Genomes, 1997, vol. 186, pp. 285-292.
Takasawa, Et al., Synthesis and Hydrolysis of Cyclic ADP-Ribose by Human Leukocyte Antigen CD38 and Inhibition of the Hydrolysis by ATP. The Journal of Biological Chemistry, 1993, vol. 268, pp. 26052-26054.
Nakagawara, Et al., Assignment of CD38, the gene encoding human leukocyte antigen CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase), to chromosome 4p15. Cytogenet Cell Genet, 1995, vol. 69, pp. 38-39.
Jackson, Et al., Isolation of a cDNA Encoding the Human CD38 (T10) Molecule, A Cell Surface Glycoprotein with an Unusual Discontinuous Pattern of Expression During Lymphocyte Differentiation. The Journal of Immunology, 1990, vol. 144, pp. 2811-2815.
Yagui, Et al., A missense mutation in the CD38 gene, a novel factor for insulin secretion: association with Type II diabetes mellitus in Japanese subjects and evidence of abnormal function when expressed in vitro. Diabetologia, 1998, vol. 41, pp. 1024-1028.
Ferraro, Et al., Human CD38, a Leukocyte Receptor and Ectoenzyme, Is a Member of a Novel Eukaryotic Gene Family of Nicotinamide Adenine Dinucleotide+-Converting Enzymes. The Journal of Immunology, 1997, pp. 3858-3865.
Savarino, Et al., Effects of the human CD38 glycoprotein on the early stages of the HIV-1 replication cycle. The FASEB Journal, 1999, vol. 13, pp. 2265-2276.
Savarino, Et al., Role of CD in HIV-1 infection: an epiphenomenon of T-cell activation or an acitve player in virus/host interactions? AIDS, 2000, vol. 14, pp. 1079-1089.
Dianzani Umberto
Savarino Andrea
McCarter & English LLP
Parkin Jeffrey S.
LandOfFree
Compositions containing anti-HIV peptides and methods for use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing anti-HIV peptides and methods for use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing anti-HIV peptides and methods for use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4110657